MedPath

A pilot study for the efficacy of the non-benzodiazepine hypnotic or orexin receptor antagonist on insomnia in major depressive patients unresponsive to benzodiazepine hypnotic treatment: a randomized open-label trial.

Not Applicable
Conditions
major depressive disorder
Registration Number
JPRN-UMIN000031032
Lead Sponsor
Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients taking other hypnotics. 2. Patients judged not to be accurately taken. 3. Patients with severe physical disease. 4. Patients with a history of severe drug hypersensitivity or drug allergy. 5. Women who are pregnant or who wish to be pregnant during the study period, and lactating mother. 6. Patients taking agents causing insomnia. 7. Patients judged to be high-risk for substance abuse. 8. Patients judged to be high risk for suicide. 9. Patients judged to be inappropriate for participation by researchers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath